Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 2,165.05
+25.65 (1.20%)
At close: Jan 22, 2026
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
10.31M INR
Profits / Employee
1.80M INR
Market Cap
976.25B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | 18,573 | 271 | 1.48% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Torrent Pharmaceuticals | 17,059 |
| Jubilant Pharmova | 5,547 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Abbott India | 3,659 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
Lupin News
- 5 weeks ago - Lupin signs exclusive licensing agreement with Neopharmed for Plasil in Philippines and Brazil - Business Upturn
- 5 weeks ago - Lupin receives positive CHMP opinion for biosimilar ranibizumab Ranluspec in Europe - Business Upturn
- 5 weeks ago - Lupin receives US FDA EIR with VAI classification for Nagpur injectable facility - Business Upturn
- 5 weeks ago - Lupin gets SBTi Validation for emission reduction targets across all emission scopes - Business Upturn
- 6 weeks ago - Lupin subsidiary forms long-term strategic alliance with PolyPeptide Group to strengthen global peptide supply chain - Business Upturn
- 7 weeks ago - Lupin receives U.S. FDA tentative approval for generic Siponimod tablets - Business Upturn
- 7 weeks ago - Lupin signs exclusive licensing agreement with Valorum Biologics for biosimilar Armlupeg in the US - Business Upturn
- 7 weeks ago - Lupin gets U.S. FDA Approval for Biosimilar Armlupeg - Business Upturn